Codex @codex  0

A protein domain that can recognize particular methylated histone states, with specificity depending on the particular protein.

In an illustrative EGFR activation route, EGF stabilizes an associated pair of receptor chains. Asymmetric contact between their protein kinase protein domains activates one catalytic partner without requiring its activation-loop phosphorylation. Subsequent phosphorylation of cytoplasmic tails creates recruitment sites. Preassociated inactive EGFR populations can also occur: the cartoon's separated starting chains are not a universal initial condition.^[ref]

An immunoglobulin heavy chain extends through an arm and the stem of the illustrated IgG.

Its IgG protein domains run from the N-terminus as $V_H,C_{H1},C_{H2},C_{H3}$: the first pair contributes to Fab fragments, the last pair to the Fc fragment.^[ref]

An immunoglobulin light chain accompanies an arm of the illustrated IgG, contributing to its paratope.

Its protein domains are $V_L,C_L$, read from the N-terminus; a Fab fragment retains both.^[ref]

Membrane topology specifies the sidedness of a membrane-associated polypeptide chain: where its N-terminus, C-terminus and intervening protein domains lie relative to the lipid bilayer. Side-specific placement is essential to interpreting a cell-surface receptor.^[ref]

For an original worked example, stipulate a continuous polypeptide chain with its N-terminus outside a biological cell, exactly three complete crossings of the cell membrane, and no additional excursions into the lipid bilayer. Its segments lie, in order, outside, inside, outside, inside. A protein domain between the first and second crossings faces the cytosol; one between the second and third faces the exterior; the C-terminus faces the cytosol. Counting crossings determines these placements without specifying an atomic protein structure.

The proof is a side-switching argument. Assign exterior the sign $+1$ and interior $-1$. Each complete crossing multiplies the sign by $-1$, so after $m$ crossings,An odd number puts the termini on opposite sides, an even number on the same side. This assumes complete crossings of one boundary; a chain that enters and returns to the same side without crossing must not be counted as a complete crossing. Nor does the rule determine which side the N-terminus starts on.

As a constructed accessibility test, put an epitope on the outside segment between crossings two and three, and another on the inside segment between crossings one and two. Stipulate an intact cell membrane that excludes the test antibody and accessible epitopes that bind it. Applying the antibody outside can label only the first epitope. If both become accessible after opening the boundary, the difference tests sidedness under those assumptions. Failure to label an epitope alone is insufficient: it could also be inaccessible because of protein folding or poor antibody affinity. This is a proposed reasoning exercise, separate from the historical mixing experiment below.

The useful product is a correctly identified, active and reproducible protein preparation, not merely a large expression band. I would first examine the coding sequence, protein sequence and available biological information to identify the likely mature chain, protein domains, signal peptides, transmembrane segments, disulfide bonds and required post-translational modifications. A predicted protein structure can guide construct boundaries, but cannot establish that the expressed product will fold or function. A eukaryotic genomic sequence containing introns generally needs replacement by an intron-free Complementary DNA or synthetic coding region for expression in Escherichia coli. I would verify the chosen isoform and full sequence, since a database annotation can be wrong.

The expression host follows from the biochemical requirements. Escherichia coli is inexpensive and convenient for many soluble proteins; yeast, insect or mammalian cells may be preferable for secreted proteins or essential glycosylation. A membrane protein also requires a suitable membrane environment during expression and an appropriate detergent or membrane mimic after extraction. I would preserve biologically necessary domains and modifications. Removing a flexible region to improve yield creates a different construct whose suitability must be justified by the intended analysis.

For a bacterial preparation, I would clone the coding region into an expression vector with a controllable promoter, a suitable ribosome-binding site, a selectable marker and a removable affinity tag. A terminal polyhistidine tag is a practical initial choice, provided the terminus is compatible with activity. Correct reading frame, both junctions and the complete insert must be checked by DNA sequencing. The T7 expression system offers strong inducible expression through a phage RNA polymerase; the original work established selective expression of cloned genes, but strong transcription alone does not guarantee soluble, active product.^[ref]

I would screen small cultures before scale-up, varying induction strength, induction duration and temperature, and comparing total lysate with soluble and insoluble fractions by SDS-PAGE. Empty-vector and uninduced controls identify host bands and background expression; an immunoblot against the tag can help identify the product. Expression at lower temperature or a weaker rate can improve protein folding; persistent insolubility may require changing the construct, host or folding environment. An inclusion body is evidence of abundant insoluble material, not of correctly folded protein. Refolding may be possible, but its yield and recovered activity need independent validation.

Once a small-scale condition produces active soluble material, I would expand the culture or fermentation while monitoring growth and retaining the validated induction conditions. After harvesting, controlled lysis at low temperature, an appropriate buffer solution and protection against proteolysis preserve the product. Centrifugation removes debris; a membrane-associated target instead requires isolation and solubilization of the relevant fraction. I would use immobilized metal affinity chromatography for a polyhistidine-tagged construct, wash away nonspecific binders, and elute under conditions compatible with activity. Tag cleavage, a second affinity step to remove tag and tagged protease, and an orthogonal separation such as ion-exchange chromatography can improve purity. A final size-exclusion chromatography step removes aggregates and separates different assemblies. No single chromatographic peak proves identity or homogeneity.

At each stage I would record protein concentration, total recovered amount and a suitable activity or binding readout, rather than optimizing yield alone. Final checks would include SDS-PAGE, intact or peptide mass spectrometry, a native-size measurement and the expected biological activity. Buffer-only and host-purification controls test whether apparent activity comes from contaminants; comparing tagged and cleaved material tests tag interference. Small frozen aliquots should be used only after checking stability and freeze–thaw effects. Scale-up is justified by recovery of the desired molecular species with retained function, with any differences from the native protein documented.

The central structural result is that strand exchange takes place on an ATP-stabilized helical protein–DNA scaffold that stretches DNA and presents its bases for complementary pairing. X-ray crystallography established local geometry and nucleotide-dependent contacts; electron microscopy, especially cryo-electron microscopy, revealed extended assemblies and captured donor-DNA-bound and strand-exchanged states. Their combination explains much of the molecular recognition mechanism while leaving the temporal sequence to be tested kinetically.

In homologous recombination, a RecA-family recombinase assembles on single-stranded DNA to make a presynaptic filament. The assembly encounters double-stranded DNA, tests nucleic acid complementarity and promotes DNA strand exchange, generating a heteroduplex DNA region. Local invasion yields a D-loop, with one strand of the donor displaced. Bacterial RecA and eukaryotic RAD51 are related but are not interchangeable descriptions of every regulatory step. In a cellular DNA repair reaction, production and protection of the initial single-stranded DNA and subsequent DNA synthesis require other factors; a structure of the recombinase core does not explain the whole pathway.

An early contribution of electron microscopy was to show that the active species is an extended nucleoprotein filament, rather than a single protein clamping two short sequences together. Helical reconstruction and comparisons across nucleotide conditions distinguish extended and more compact assemblies. This organization suggested collective control: neighboring subunits could coordinate DNA binding and ATP state. Low-resolution filament dimensions alone could not locate individual bases or prove which contacts recognize complementarity; those questions required higher-resolution structures and biochemical tests.

The RecA–DNA crystal structures made that geometry explicit. They showed ATP-state-dependent contacts across neighboring RecA subunits and DNA held inside the helical assembly. The DNA is globally extended and underwound, while short three-base groups retain approximately ordinary local base geometry. Separation is concentrated between these groups. Thus the protein reshapes the overall substrate without making every adjacent base pair equally distorted. The related single-stranded DNA and heteroduplex DNA structures further showed that the incoming complementary strand is supported substantially through base pairing, providing a structural explanation for sequence dependence.^[ref]

This geometry has several mechanistic consequences. Organizing bases into small groups makes a local complementarity test possible before a long donor region has been opened. The scaffold also exposes DNA bases while imposing an energetic and geometrical cost on bringing intact donor double-stranded DNA into the same arrangement. Favorable new Watson-Crick base pairing can compensate for disrupting old pairing. Because RecA mainly organizes the searching strand rather than reading a fixed base sequence with a sequence-specific pocket, the same recombinase can act at many genomic sequences. These are mechanistic interpretations of the structures, not direct measurements of search speed.

The nucleotide-binding site lies at the subunit interface, so ATP binding and DNA affinity are coupled to filament organization. A change in nucleotide state can consequently affect several neighboring contacts rather than only a local catalytic site. Distinguish two roles: ATP binding stabilizes a strand-exchange-competent arrangement, whereas ATP hydrolysis supports filament turnover and completion of physiological reactions. A structure trapped with a nucleotide analogue cannot establish that one ATP is hydrolyzed for every base pair exchanged. Testing that assertion would require simultaneous nucleotide-turnover and strand-exchange measurements, including reactions lacking complementarity.

Crystallography also imposes selection. A continuous filament is hard to crystallize in a way that resolves its DNA, so engineered finite assemblies and stabilized nucleotide conditions can be useful. Crystal contacts, linked subunits or trapped intermediates may restrict the accessible structures. The strength of the result lies in an explicit atomic arrangement that explains independent observations; the limitation is that a stable crystal state does not reveal the distribution or lifetime of all intermediates in solution. Cross-check filament geometry in electron microscopy, test activity of the crystallized construct, and mutate candidate contacts while measuring assembly as well as DNA strand exchange.

cryo-electron microscopy extended this interpretation to human RAD51. Structures of presynaptic and postsynaptic RAD51–DNA filaments demonstrated conservation of the central scaffold and also identified differences in subunit interfaces and DNA interactions. An arrested synaptic assembly supplied evidence about the stage in which the donor has encountered the searching filament.^[ref] This supports a common mechanistic framework across organisms without assuming identical nucleotide kinetics, regulatory partners or sequence discrimination. It is particularly useful to compare like nucleotide and substrate conditions, because structural differences can otherwise reflect preparation rather than a genuine species difference.

A more direct view of the donor encounter came from cryo-electron microscopy of RecA synaptic and D-loop assemblies. In those structures the C-terminus-containing protein domain of RecA recruits donor double-stranded DNA; a DNA-binding loop helps open the duplex. The displaced strand is accommodated at a secondary binding region while the complementary strand can pair with the initiating single-stranded DNA. Structures with limited complementarity locate the new heteroduplex DNA and its junctions to the remaining donor duplex.^[ref] This supplies a physical route from donor capture to a local pairing test and then strand displacement, rather than inferring the entire reaction merely from its endpoints.

The general model is a series of reversible local tests. Nonmatching encounters should tend to close or detach before opening a long region; favorable complementarity should permit longer-lived opening and extension. This avoids requiring every genomic encounter to pay the energetic cost of unwinding a long donor segment. Multiple structures support that interpretation, but their existence alone does not establish which state precedes which, how rapidly they interconvert, or the probability of successful invasion in a biological cell. Population fractions after trapping can differ from flux through the working reaction.

A discriminating experimental programme would compare homologous and mismatched donors of the same length, an active versus altered donor-opening loop, and ATP versus an appropriate trapped nucleotide state. Measure DNA binding, filament formation, nucleotide turnover and D-loop yield separately. A donor-opening mutation that abolishes D-loop formation while retaining a normal presynaptic filament is stronger evidence for its proposed role than a mutation that simply unfolds the protein. Check structures of the altered complex where possible. Time-resolved Förster resonance energy transfer or other single-molecule assays can test donor opening and exchange, with labels positioned and controlled so that unwinding is not confused with aggregation or spontaneous strand displacement. Structures identify the scaffold and candidate intermediates; complementary binding, kinetic and mutational experiments establish how that scaffold performs a productive homology search.

Separate three causal steps: recognition of the modified RNA, occupancy of the target messenger RNA, and reduction of its degradation rate. Call the newly identified RNA-binding protein R. Its recovery in a screen need not mean it contacts the modified ribonucleotide directly; it could recognize a modification-dependent structure or arrive through another protein. Likewise, more target messenger RNA could reflect increased transcription rather than greater stability.

First reproduce the interaction using endogenous R and the endogenous target. Determine R's protein domains, expression and subcellular distribution, then use reciprocal RNA immunoprecipitation and crosslinking and immunoprecipitation to locate the occupied region. Normalize enrichment to input target abundance and R recovery, and include unrelated RNAs, a non-specific antibody and cells lacking R. Crosslink-based occupancy supports close contact, whereas recovery without crosslinking can preserve indirect complexes. Determine whether the relevant modification actually occurs near the binding site: mass spectrometry of purified target fragments can establish chemical identity, supplemented by a modification-specific mapping assay with known modified and unmodified standards. Bulk mass spectrometry of all cellular RNA cannot assign a modification to this particular transcript or position. Do not assume the modification is N6-methyladenosine merely because it is familiar.

Prepare short synthetic RNAs identical in nucleotide sequence, length, ends and labelling except for the single modified ribonucleotide. Measure binding of purified R over a concentration range by electrophoretic mobility shift assay or fluorescence anisotropy, with competition by unlabelled cognate and unrelated RNA. The dissociation constant distinguishes a quantitative preference from a binary pull-down impression. Verify that R is folded and sufficiently pure; include an RNA-binding-defective R mutant, several surrounding sequences and different modification positions. Modification-specific recovery from a cellular extract can disappear with purified R, revealing a missing partner rather than disproving the original screen.

Distinguish chemical recognition from structural recognition. Compare RNA secondary structure with and without the modification by RNA structure probing. Then disrupt the stem without changing the binding motif, or restore pairing through compensatory mutations. If an unmodified but constitutively exposed motif binds R, and restoring occlusion suppresses binding even when the modification remains, an RNA modification switch is plausible. Direct recognition is supported when modification discrimination persists after accessibility is matched and is lost upon a specific R binding-pocket mutation. Structural work can identify the contacts, but binding and structure controls remain essential. Modification-dependent exposure of a binding motif has an experimental precedent in the N6-methyladenosine-dependent RNA modification switch for HNRNPC.^[ref]

Establish stability by acute depletion of R, followed by a metabolic RNA labelling pulse and chase. Measure loss of labelled target molecules using appropriate spike-ins and a time course spanning the expected half-life, while independently estimating newly synthesized target RNA. SLAM-seq is one possible implementation: chemical treatment makes incorporated 4-thiouridine detectable through characteristic sequencing changes.^[ref] Include unlabelled controls, check label toxicity and correct for label reutilization or incomplete chase. When reporting molecules per biological cell, separate dilution through increasing cell number from chemical degradation. A transcription inhibitor time course provides an orthogonal check, but broad inhibition itself can change decay. Under a constant first-order degradation model, labelled molecules obeyA shorter half-life after R depletion, reversed by normal R but not its RNA-binding-defective mutant, establishes the proposed effect. Allow a more complex fit if the exponential decay model is inconsistent with the measured time course. At steady state, abundance is synthesis rate divided by degradation rate, so abundance alone cannot identify which rate changed.

Use a controlled target reporter gene carrying the occupied region, then remove or mutate that region and measure reporter messenger RNA decay. Preserve polyadenylation, RNA splicing and coding potential where possible, and distinguish site loss from altered RNA secondary structure. Manipulate the relevant modification-producing enzyme acutely, rescuing with normal or catalytically inactive enzyme; verify target-site modification after the manipulation. Cross the two perturbations: if R stabilizes the target specifically through the modification, removing the modification should reduce R occupancy and eliminate or substantially weaken the extra effect of removing R. This epistasis supports a shared pathway, but floor effects or redundant sites can obscure it. A site-specific chemically modified reporter helps separate local recognition from the many indirect consequences of removing a global modification enzyme.

Identify the affected decay step using poly(A) tail measurements, cap-state assays and mapping of decay intermediates. Test whether R excludes a microRNA-loaded Argonaute complex or a decay-promoting RNA-binding protein, blocks an endonuclease, inhibits deadenylation or decapping, or recruits a protective partner such as poly(A)-binding protein. Use protein interaction analysis with and without ribonuclease to distinguish RNA-bridged association from a more direct interaction. R mutants that retain target binding but lose a partner interaction separate recruitment from recognition. Depleting the implicated decay factor should suppress the destabilization caused by R loss; purified-system decay assays can test whether R alone physically protects the substrate.

Measure biological translation and subcellular location in parallel, using ribosome profiling or a controlled biological translation reporter and single-molecule fluorescence in situ hybridization. R might stabilize the target indirectly by altering ribosome loading or compartment access. Inhibiting biological translation can itself alter decay, and colocalization in a granule does not establish protection. The reported stabilizing action of IGF2BP proteins on modified targets provides a candidate mechanism to compare with, rather than an identity to assign to R.^[ref] The strongest mechanism links a verified target-site modification to R binding, a defined protective activity and a rescued change in target half-life.

The main diagonal contains relatively dark blocks separated by much paler off-diagonal regions. This supports a modular protein with internally more confidently predicted regions but uncertain relative packing. In particular, the broad early region ending near residue 650 and the later region are poorly positioned relative to one another. Smaller blocks within these regions suggest further domain subdivision.

Thus the compact-looking arrangement in the ribbon drawing should not be treated as a uniquely established structure of the whole enzyme. The matrix can suggest protein domain boundaries and flexible inter-domain relationships; it neither proves domain independence experimentally nor establishes that uncertainty is caused by a particular motion.

Reusable protein domains make evolution combinatorial: a new domain combination can join an existing catalytic activity to a binding, localization or regulatory module without inventing every component anew. Gene duplication allows one copy to retain an established role while another diverges; domain shuffling and fusion can create new combinations. Connecting domains can also increase effective local concentration of interacting sites or enable allostery.

These are potential advantages, not guarantees that every fusion is beneficial: domains must still fold and work together. The domain-level analysis behind this example found extensive reuse and new combinations of recognized structural units.^[ref]

In single-molecule force spectroscopy of titin, one end of the protein is attached to a surface and the other to an atomic force microscope cantilever. Moving the support stretches the molecule; a calibrated cantilever deflection measures the force through $f=k_c\delta$. The molecular extension is the imposed separation minus cantilever deflection and other instrumental offsets, rather than the uncorrected support displacement.

At first, increasing extension removes conformational slack from unstructured segments. Their conformational entropy decreases and the resisting force rises. A folded protein domain then unfolds when a thermally activated transition becomes likely under load. Its residues join the stretched chain, increasing the available polymer contour length. At almost the same imposed separation, the newly released segment has slack: the force drops. Further pulling straightens this longer chain until another domain unfolds. Repetition produces a sawtooth sequence; each rising branch mainly measures stretching between unfolding events, and a peak marks the end of such a branch.

The peak height measures the resistance to unfolding under the particular loading history, not a direct equilibrium free energy or an invariant breaking force. Random unfolding times, loading rate, domain identity, attachments, and cantilever compliance affect the record. Releasing tension can allow protein folding, but refolding has its own kinetics and need not retrace the loading curve. Distinct unfolding events explain how a long protein can absorb extension in steps rather than failing at a single threshold.

Source illustration TODO: Figures A and B are absent in the held source and archive parent. This explanation uses the surviving sawtooth description; it supplies no recovered peak heights, spacings, or domain counts.

An inextensible worm-like chain describes entropic elasticity and diverges as $x\to L$. Real protein backbones and folded protein domains also deform energetically under large forces. For an axial stretch modulus $K_s$, a simple extensible-chain correction isThe last term supplies extension through bond and structural deformation that the inextensible model excludes. It becomes especially noticeable on the high-force ends of rising branches.^[ref] An unfolding transition itself is also outside a single equilibrium fixed-$L$ branch. These mechanisms explain why the source explicitly distinguishes energetic and entropic elasticity.

Source-dependent TODO: the arrows and actual deviations at the first four peaks in Figure B are unavailable. Energetic stretching is the natural explanation of a high-force excess-extension deviation, but its direction, onset, and uniqueness cannot be checked against the missing curves. No particular arrow-marked feature or numerical stretch modulus is invented. This source-dependent identification remains incomplete; the recoverable model limitation is explained above.

After a domain unfolds, its backbone joins the same continuous chain as previously unfolded material. The new branch differs mainly by an added contour length, while the local backbone bending statistics remain similar. It is therefore consistent to fit successive branches with different $L_j$ and one common $L_p\simeq 0.8\mathrm{nm}$. Tension is transmitted through serial portions of the same chain; one should not add their tensile forces as though they were independent parallel springs.

The persistence length is short compared with the contour increment per repeat, so each released domain contributes many flexible bending segments. Stretching suppresses those thermal modes and raises free energy through loss of entropy, which is precisely the worm-like-chain mechanism. The common $L_p$ is a property of the unfolded backbone under the measurement conditions, not the folded domain's axial length or the number of domains already released. With $T=300\mathrm{K}$ only as an illustrative value, $k_{B}T{L}_p\simeq 3.3\mathrm{pN}\mathrm{n}{\mathrm{m}}^2$.

A common persistence-length fit is evidence for approximately repeat-independent chain flexibility over the observed branches; it is not proof that a continuum inextensible model describes every molecular scale. Residual folded structure, heterogeneous linkers, force-induced backbone stretching, and very short-chain effects can cause deviations. The formal force divergence at $x=L$ signals the model's inextensibility assumption, not a physical infinite tensile force.

Protein primary structure is the ordered amino acid sequence of a polypeptide, linked by covalent peptide bonds. The approximately planar peptide bond restricts local geometry, while backbone torsion angles give conformational freedom subject to steric exclusion. Protein secondary structure comprises local backbone arrangements, especially the alpha helix, with backbone hydrogen bonds between residues $i$ and $i+4$, and the beta sheet, whose strands are joined by backbone hydrogen bonds. Turns and loops connect these elements. Protein tertiary structure is the full three-dimensional organization of a single chain, often including several protein domains. Protein quaternary structure is the arrangement of multiple chains in a protein complex.

Protein folding is governed by the Gibbs free energy of the chain together with its solvent, not by the chain's energy alone. Folding reduces the chain's conformational entropy, but can gain solvent entropy through the hydrophobic effect, burying nonpolar side chains away from water. Favorable hydrogen bonds, Van der Waals forces, electrostatic interactions and sometimes covalent disulfide bonds stabilize particular structures. Steric repulsion prevents atomic overlap. At fixed temperature and pressure, the native ensemble is favored when its total $\Delta G=\Delta H-T\Delta S$ is lower than competing ensembles. The balance depends on the solvent, pH, salt and ligands. Molecular chaperones help avoid aggregation or kinetic traps; a stable fold is not a perfectly rigid conformation, and some proteins have disordered regions.

For a soluble globular protein, a typical pattern is a nonpolar core and a polar, hydrated surface. A transmembrane protein instead presents nonpolar side chains to the hydrocarbon interior of the lipid bilayer. Membrane-spanning alpha helices satisfy their polar backbone groups through internal hydrogen bonds; a roughly membrane-thickness helix commonly contains about twenty residues, depending on tilt and bilayer thickness. Multiple helices can enclose polar channels or binding sites. Membrane-spanning beta barrels likewise expose mainly nonpolar groups outward towards lipid while arranging backbone hydrogen bonds between strands and often lining an aqueous pore with polar groups. Exposed loops and domains contacting water can resemble soluble proteins. Not every membrane-associated protein spans the membrane: peripheral attachment and lipid anchoring are distinct possibilities.

The organizing distinction is the environment of each surface: water favors accessible polar groups, while the membrane core favors outward-facing nonpolar groups. Buried polar groups can still be essential to a transport pathway or catalytic site.

The protein primary structure is the ordered protein sequence along a polypeptide, from its N-terminus to its C-terminus. In cells, information in a DNA coding sequence is copied into messenger RNA by transcription. During translation, the ribosome reads successive three-base codons; transfer RNA molecules match these by their anticodons and supply the corresponding amino acids. The genetic code is degenerate: different codons can encode the same amino acid. A start establishes the reading frame and a stop terminates translation. Peptide bonds link the amino acids into the backbone, leaving chemically different side chains. Thus the sequence specifies the order of side-chain interactions, rather than a literal coordinate list for the folded molecule.

Protein secondary structure describes local backbone arrangements. An alpha helix is stabilized by a regular pattern of backbone hydrogen bonds, typically between the carbonyl of residue $i$ and the amide of residue $i+4$. Beta sheets assemble extended strands through inter-strand hydrogen bonding, with parallel or antiparallel strand orientations. Turns and loops connect these elements; not every region belongs to a helix or sheet. The peptide bond is approximately planar, while backbone torsion angles provide conformational freedom subject to steric restrictions.

Protein tertiary structure is the complete three-dimensional organization of one chain, often arranged into protein domains. Protein quaternary structure describes the organization of multiple chains in an assembly. Soluble globular proteins often bury nonpolar side chains and expose polar ones; membrane proteins can instead expose hydrophobic surfaces to the surrounding lipid. Other stabilizing interactions include hydrogen bonds, electrostatic interactions, Van der Waals forces and sometimes covalent disulfide bonds. These competing contributions define active sites, binding pockets and mechanically useful structures; folded proteins are dynamic ensembles, not perfectly rigid objects.

The connection from sequence to structure is thermodynamic and kinetic. Folding usually decreases the chain's conformational entropy, but favorable interactions and changes in solvent entropy, including the hydrophobic effect, can lower the total Gibbs free energy. Under suitable conditions the native ensemble is favored over unfolded alternatives. A change in sequence can therefore change the balance of accessible conformations and alter folding or function. Reversible refolding of a denatured protein in an appropriate environment demonstrates that the sequence can contain the information needed for its native structure.^[ref]

The environment is part of the specification: temperature, pH, ionic conditions, ligands and post-translational modifications matter. Molecular chaperones can prevent aggregation and help chains escape kinetic traps without providing a residue-by-residue structural template. Some sequences are intrinsically disordered proteins or disordered regions, and some require partners for a stable fold. Thus primary structure strongly constrains structure, but does not guarantee one unique rigid shape independent of conditions.

AlphaFold has transformed structural research, but experimental structural biology remains necessary to establish biological states, test predictions and measure properties that a predicted structure does not specify. The proposition becomes plausible only if structural biology is restricted to producing a single set of coordinates from a protein sequence; its actual questions extend well beyond that task.

The achievement should not be minimized. AlphaFold 2 showed that learned sequence and structural relationships could yield exceptionally accurate protein structure predictions, with strong performance in the blind CASP14 assessment. The result made useful structural hypotheses available for many proteins for which conventional structure determination was difficult. Its learned geometric representations and use of evolutionary information were a substantial advance over simply transferring a close template.^[ref] Such models can reveal likely protein domains, suggest candidate active sites, guide construct design and focus expensive experiments on specific uncertainties.

By the examination date, the scope had already expanded. The AlphaFold 3 paper, published online on 8 May 2024, described joint prediction of assemblies containing proteins, nucleic acids, small molecules, ions and modified residues. It is therefore inaccurate to reject the proposition merely by claiming that every AlphaFold version is restricted to an isolated unmodified protein chain. Its own paper nevertheless documents incorrect stereochemistry, clashes, spurious ordering of disordered regions and limited conformational coverage.^[ref]

The central distinction is between a plausible coordinate model and a measurement of a particular sample. A predicted interface does not establish that the molecules encounter each other in a cell, associate at physiological concentrations or form the proposed stoichiometry. A predicted ligand pose does not supply its binding affinity, association and dissociation rates, or functional efficacy. An apparent active-site geometry does not measure an enzyme's catalytic rate or establish which reaction it performs. Those are different observables, requiring appropriate biochemical, biophysical or cellular experiments. Some of these experiments are outside structural determination narrowly understood, which further shows why coordinate prediction alone cannot close the biological question.

Many proteins also act through a conformational ensemble. Allostery, gating and mechanochemical cycles concern transitions between states, their occupancies and their timescales. One accurate fold is not a measurement of that ensemble. Nor does generating several predictions with different random seeds make their frequencies estimates of equilibrium populations: prediction sampling is not automatically sampling from a physical Boltzmann distribution. The AlphaFold 3 authors explicitly distinguish their static predictions from the solution ensemble.^[ref] An intrinsically disordered region may be biologically functional precisely because a single rigid structure is an inadequate description.

Confidence information helps select what to trust, but has to be interpreted correctly. pLDDT assesses predicted local structural accuracy on a 0–100 scale; it is not the probability that an entire structure is correct or that the protein performs a proposed function. predicted aligned error addresses the relative placement of parts of a model. Two domains can each have convincing local folds while their mutual arrangement is uncertain. High confidence is useful evidence about the predictor's expected geometric accuracy, but is not independent experimental confirmation of a novel interaction.^[ref]

The different experimental methods answer complementary questions. X-ray crystallography constrains coordinates through observed diffraction and can resolve ligands or alternative states in suitable samples, although crystallization and refinement can introduce biases. cryo-electron microscopy can examine large assemblies and classify heterogeneous conformations, subject to sample preparation, resolution and reconstruction limitations. nuclear magnetic resonance provides solution-state structural constraints and measurements sensitive to molecular dynamics, with its own size and sensitivity restrictions. cryo-electron tomography can place macromolecular organization in a cellular context. None is a perfect photograph of unrestricted physiological reality; each yields data requiring a model and appropriate validation.

The practical relationship is increasingly reciprocal. A predicted structure can seed molecular replacement in X-ray crystallography or help interpret a cryo-electron microscopy density map. The resulting model must still be checked against the experimental signal, including information not used to optimize it. Otherwise, model bias can make a plausible prediction appear experimentally confirmed simply because it was imposed during fitting. Where two structural hypotheses predict different contacts or movements, targeted site-directed mutagenesis, binding measurements or dynamic measurements can discriminate them. An altered phenotype after a mutation alone is not definitive structural validation, because the mutation may instead destabilize the protein or affect expression.

Experiments also underpin evaluation of the predictor itself. Experimental structures in the Protein Data Bank supply much of the structural evidence used for learning and benchmarking. Tests on genuinely withheld targets, with attention to homologous structures and related complexes in training, are more informative than agreement with a familiar case. Experimental determination of unusual folds, environments or complexes can expose failure modes that confidence scores have not yet captured. A prediction method that learns from experimental structures does not thereby make every new experiment redundant.

The justified conclusion is a change in the allocation of effort. Determining the fold of a routine, confidently predicted domain may no longer be the most informative use of experimental resources. Establishing state changes, interactions, ligand chemistry, dynamics and genuinely novel biology becomes more valuable. AlphaFold reduces some structural uncertainty and accelerates experiments; it does not turn structural hypotheses into measurements or make experimental structural biology obsolete.

Central hypothesis and objectives. PUF50 participates in one or more protein assemblies whose composition or activity affects Wnt signalling. The proposal should distinguish membership, direct binding and causal pathway regulation. The three aims are to nominate plausible partners, identify reproducible cellular complexes, and test whether a supported interaction explains the phenotype.

Computational starting point. Inspect the verified PUF50 sequence for protein domains, localization signals, conserved residues and predicted disordered regions. Use sequence alignment and orthology to compare well-annotated homologues, recording uncertainty in functional transfer. Public interaction and expression resources can nominate partners expressed in the experimental cell line. Structural predictions can prioritize testable interfaces, but a confident fold alone does not establish a cellular interaction or tumour-suppressor function.

Discovery proteomics. Use affinity purification-mass spectrometry to compare PUF50-associated material with matched negative controls across independent biological replicates. An endogenous or functionally validated tagged preparation is preferable to assuming that strong overexpression preserves normal localization and complex stoichiometry. Tag-only controls, input abundance measurements and an unrelated bait help distinguish reproducible association from abundant or sticky contaminants. Quantitative enrichment should be evaluated together with replicate consistency and a controlled false discovery rate.

Complexes may vary with pathway state. Compare a relevant baseline and a defined Wnt-responsive state, checking that changes in recovered partner abundance are not explained solely by input abundance, cell number or viability. If transient or compartmentalized partners are missed, proximity labeling can provide complementary neighbourhood evidence. Its hits should be labelled as proximity associations rather than automatically promoted to direct complex subunits.

Independent validation and mechanism. Validate leading associations by reciprocal co-immunoprecipitation and localization evidence. Where a direct interaction is important to the proposed mechanism, test it with an independent assay suited to the relevant protein domains. A genetic perturbation and rescue comparison can ask whether loss of PUF50 changes pathway output and whether restoring PUF50 restores it. Compare pathway-proximal measurements with downstream transcription and longer-term growth phenotypes, because a growth defect alone is not specific to Wnt regulation.

A separation-of-function comparison is especially informative: a PUF50 variant that retains abundance and localization but loses a supported partner association could help connect the interaction to function. This interpretation requires checking folding and stability, since an inactive misfolded protein does not isolate one interface's role. Genetic interaction analysis can then place PUF50 relative to known pathway components without treating every correlated expression change as a direct target.

Analysis, deliverables and alternatives. Integrate quantitative interaction evidence, localization and perturbation responses into an annotated protein interaction network, retaining evidence type on each edge. Report effect sizes and uncertainty, include unsuccessful validation, and release analysis code with processed data. A negative stable-complex result would motivate a transient or condition-specific interaction hypothesis rather than proving that PUF50 acts alone. The principal deliverable is a ranked, experimentally qualified set of complexes and a causal test of the most supported pathway mechanism.

Objective and rationale. Build an evidence-traceable genome resource for the organism described in the question, then improve its gene structures using one genome-wide experiment: replicated, strand-aware RNA sequencing across a deliberately chosen range of growth conditions. The species name is treated as part of the hypothetical study; no established gene catalogue is assumed.

Poor annotation limits both discovery and interpretation. Missing exons distort protein sequences, merged or split gene models create false absences and duplications, and unrecognized transcripts bias expression analyses. Functional claims transferred to an incorrectly predicted protein can then compound the original error. Reliable coordinates, gene identifiers and evidence provenance are therefore prerequisites for a comparative model system.

Resource construction. Assemble a versioned reference containing the genome assembly, existing gene models, published sequence evidence and curated cross-references. Reconcile naming and coordinates, flag conflicting gene structures, and document assembly gaps and repetitive regions. Compare predicted proteins with well-annotated yeast homologues using orthology, conserved domain architecture and, where informative, conserved gene neighbourhoods. Sequence similarity is evidence for a relationship; it is not sufficient to give every paralogue its best hit's exact function.

Genome-wide experiment. Use RNA sequencing to supply transcript evidence from independent biological samples covering contrasting physiological states. Multiple conditions broaden the chance of observing condition-specific genes, but read counts within a library remain technical observations, not extra biological replicates. Quality-control and strand-aware alignment would assess mapping uniqueness, exon coverage and splice junction support. Reference-guided and appropriately checked transcript assembly can identify expressed loci absent from the current annotation and suggest corrected exon boundaries, alternative transcripts and untranslated regions.

Integrate these data with protein homology and gene-prediction evidence. A proposed exon should have coherent splice support and coding plausibility; an isolated ambiguous read is insufficient. Keep alternative models and confidence levels when repeat structure or incomplete coverage prevents a unique assignment. No expression in the sampled conditions should be recorded as lack of evidence, not proof that a gene is absent.

Validation and functional annotation. Validate a representative set of corrected and new models by targeted transcript and junction checks, prioritizing models whose revision changes a predicted protein domain or conserved function. Retain known positive controls and distinguish biological alternatives from assembly or mapping errors. Transfer broad functional terms conservatively using orthology and domain evidence, with explicit evidence codes and source organisms; a computationally inferred function remains distinct from an experimental demonstration.

RNA sequencing improves expressed gene structures and condition-specific expression annotation, but it does not repair every assembly gap, establish translation of every transcript, or identify every gene's biochemical activity. Those limitations should remain visible in the resource. The deliverables are a searchable genome browser, stable identifiers, versioned gene models and downloadable evidence tracks, together with a reproducible update process that preserves previous releases and community corrections.

A protein domain is a distinguishable structural and functional region of a protein. A catalytic protein domain and a binding protein domain can carry out different tasks within one chain.

A receptor tyrosine kinase combines extracellular ligand recognition with an intracellular protein kinase protein domain. A membrane-spanning segment connects these parts across the cell membrane: the signal changes the intracellular machinery without requiring the ligand to enter the cytosol. The protein kinase transfers a phosphate group from ATP to selected tyrosine residues on proteins, including the receptor itself.^[ref]

This architecture makes a reception event useful in two ways: it can change catalytic activity and assemble a local group of signaling proteins. Trans-autophosphorylation can create phosphotyrosine residues recognized by SH2 domains. Recruitment positions a downstream enzyme or relay protein near its partners. Neither every modified site nor every recruited protein has the same effect; association is a specific molecular connection, rather than a universal command to activate everything nearby.^[ref]

Compare the epidermal growth factor receptor with the insulin receptor. Their common topology does not impose one activation geometry or make assembly equivalent to activity. The receptor phosphorylation assay consequently needs more than evidence that two protein chains associate.